Concordance of MTOR Pathway Mutations and the Diagnosis of Renal Low-Grade Oncocytic Tumor (LOT).

Siegmund, Stephanie E; Al-Obaidy, Khaleel I; Tsai, Harrison K; Idrees, Muhammad T; Akgul, Mahmut; Acosta, Andres M; Hirsch, Michelle S

Siegmund, Stephanie E; Al-Obaidy, Khaleel I; Tsai, Harrison K; Idrees, Muhammad T; Akgul, Mahmut; Acosta, Andres M; Hirsch, Michelle S.

Afiliação

Siegmund SE; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Al-Obaidy KI; Department of Pathology, Indiana University School of Medicine, Indianapolis, IN, USA.
Tsai HK; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Idrees MT; Center for Advanced Molecular Diagnostics, Brigham and Women's Hospital, Boston, MA, USA.
Akgul M; Department of Pathology, Indiana University School of Medicine, Indianapolis, IN, USA.
Acosta AM; Department of Pathology, Albany Medical Center, Albany, NY, USA.
Hirsch MS; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Int J Surg Pathol ; 32(2): 316-330, 2024 Apr.

Article em En | MEDLINE | ID: mdl-37357748

Assuntos

Adenoma Oxífilo; Carcinoma de Células Renais; Neoplasias Renais; Humanos; Carcinoma de Células Renais/diagnóstico; Carcinoma de Células Renais/genética; Adenoma Oxífilo/diagnóstico; Adenoma Oxífilo/genética; Neoplasias Renais/diagnóstico; Neoplasias Renais/genética; Mutação; Diagnóstico Diferencial; Serina-Treonina Quinases TOR/genética; Biomarcadores Tumorais/genética

Palavras-chave

LOT; MTOR; RHEB; TSC; kidney; oncocytic; renal

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Adenoma Oxífilo / Neoplasias Renais Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google